InvestorsHub Logo
Followers 63
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: None

Wednesday, 05/11/2022 7:52:15 AM

Wednesday, May 11, 2022 7:52:15 AM

Post# of 722035
Clearly, the data we saw yesterday makes this drug approvable everywhere!

3 mo gain on mOS in for ndGBM
3x 5year OS in ndGBM
Even better outcome in rGBM
Global manufacturing in place
Miss on a surrogate endpoint PFS which is explainable by MOA and a surrogate for survival (see above)
Maybe the safest drug every studied
A rare disease, universally fatal population in a horrible disease with poor Quality of Life after diagnosis.

NO BRAINER (no pun intended as it would be completely insensitive)

BLAs have already been submitted and will be approved IMO!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News